Columbia Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.77M Sell
21,458
-962
-4% -$329K 1.35% 20
2026
Q1
$7.89M Sell
22,420
-583
-3% -$208K 1.5% 14
2025
Q4
$7.53M Buy
23,003
+62
+0.3% +$19.7K 1.34% 18
2025
Q3
$6.47M Buy
22,941
+273
+1% +$79.2K 1.21% 20
2025
Q2
$6.33M Buy
22,668
+1,169
+5% +$331K 1.24% 18
2025
Q1
$6.7M Sell
21,499
-697
-3% -$206K 1.31% 16
2024
Q4
$5.79M Sell
22,196
-876
-4% -$260K 1.06% 23
2024
Q3
$7.43M Buy
23,072
+111
+0.5% +$36.3K 1.3% 19
2024
Q2
$7.17M Buy
22,961
+1,792
+8% +$526K 1.34% 19
2024
Q1
$6.1M Hold
21,169
1.24% 20
2023
Q4
$6.1M Sell
21,169
-2
-0% -$545 1.24% 20
2023
Q3
$5.69M Buy
21,171
+264
+1% +$65.9K 1.26% 20
2023
Q2
$4.64M Sell
20,907
-287
-1% -$66.6K 0.99% 31
2023
Q1
$5.12M Buy
21,194
+580
+3% +$142K 1.15% 28
2022
Q4
$5.41M Buy
20,614
+78
+0.4% +$20.9K 1.31% 22
2022
Q3
$4.63M Buy
20,536
+117
+0.6% +$28.4K 1.22% 21
2022
Q2
$4.97M Buy
+20,419
New +$5M 1.26% 22
2021
Q4
$4.23M Buy
18,791
+754
+4% +$159K 0.86% 40
2021
Q3
$3.84M Buy
18,037
+205
+1% +$47.2K 0.84% 40
2021
Q2
$4.35M Sell
17,832
-6,365
-26% -$1.57M 0.96% 36
2021
Q1
$6.02M Buy
24,197
+35
+0.1% +$8.35K 1.09% 27
2020
Q4
$5.55M Sell
24,162
-489
-2% -$113K 1.12% 28
2020
Q3
$6.26M Sell
24,651
-4,678
-16% -$1.16M 1.44% 21
2020
Q2
$6.92M Buy
29,329
+540
+2% +$123K 1.66% 16
2020
Q1
$5.84M Buy
28,789
+416
+1% +$90.9K 1.44% 19
2019
Q4
$68.4K Buy
28,373
+446
+2% +$98.3K 1.65% 18
2019
Q3
$5.4M Buy
27,927
+780
+3% +$150K 1.41% 22
2019
Q2
$5M Sell
27,147
-1,166
-4% -$209K 1.32% 23
2019
Q1
$5.38M Sell
28,313
-252
-0.9% -$48.1K 1.44% 22
2018
Q4
$5.56M Sell
28,565
-343
-1% -$66.9K 1.69% 20
2018
Q3
$5.99M Buy
28,908
+1,042
+4% +$205K 1.56% 19
2018
Q2
$5.14M Buy
27,866
+1,171
+4% +$207K 1.5% 21
2018
Q1
$4.55M Buy
26,695
+546
+2% +$100K 1.33% 23
2017
Q4
$4.55M Buy
26,149
+856
+3% +$151K 1.3% 25
2017
Q3
$4.72M Buy
25,293
+832
+3% +$147K 1.45% 21
2017
Q2
$4.21M Buy
24,461
+761
+3% +$124K 1.36% 22
2017
Q1
$3.89M Buy
23,700
+2,238
+10% +$372K 1.3% 23
2016
Q4
$3.14M Buy
21,462
+1,547
+8% +$233K 1.06% 34
2016
Q3
$3.32M Buy
19,915
+341
+2% +$57.7K 1.16% 28
2016
Q2
$2.98M Buy
19,574
+2,305
+13% +$358K 1.06% 30
2016
Q1
$2.59M Buy
17,269
+238
+1% +$35.4K 0.95% 33
2015
Q4
$2.77M Buy
17,031
+111
+0.7% +$17.4K 1.11% 27
2015
Q3
$2.34M Sell
16,920
-25
-0.1% -$3.94K 0.95% 32
2015
Q2
$2.6M Buy
16,945
+145
+0.9% +$23.2K 0.99% 31
2015
Q1
$2.69M Sell
16,800
-125
-0.7% -$19.7K 1.01% 29
2014
Q4
$2.7M Buy
16,925
+695
+4% +$108K 1.04% 28
2014
Q3
$2.28M Hold
16,230
0.92% 33
2014
Q2
$1.92M Buy
16,230
+885
+6% +$102K 0.78% 40
2014
Q1
$1.89M Buy
15,345
+2,953
+24% +$358K 0.82% 40
2013
Q4
$1.41M Buy
+12,392
New +$1.41M 0.63% 50

Other funds holding AMGN

Columbia Asset Management's AMGN Position: Q2 2026 in Review

Columbia Asset Management reduced its Amgen (AMGN) stake by 4.3% in Q2 2026, selling an estimated $329K and leaving 21,458 shares worth $7.77M. The position accounts for 1.35% of the portfolio, ranked #20.

Columbia Asset Management first reported a position in AMGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $7.89M in Q1 2026. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Columbia Asset Management held 21,458 shares of Amgen worth $7.77M as of Q2 2026.
  • Columbia Asset Management sold 962 Amgen shares in Q2 2026, an estimated $329K.
  • Amgen made up 1.35% of Columbia Asset Management's portfolio in Q2 2026, its #20 holding.
  • Columbia Asset Management first reported a position in Amgen in Q4 2013 and has held it in 50 quarters since.
  • Columbia Asset Management's Amgen position peaked at $7.89M in Q1 2026.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Columbia Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.